Vladimír Koza

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

Jürgen Finke, Wolfgang Bethge, Claudia Schmoor et al. · The Lancet Oncology · 2009 · 705 citations

Unrelated Donors, Graft-versus-host Disease, Transplantation +12

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

Enric Carreras, Hartmut Bertz, William Arcese et al. · PubMed · 1998 · 344 citations

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Gèrard Socié, Claudia Schmoor, Wolfgang Bethge et al. · Blood · 2011 · 302 citations · Full text

A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours

J L Pico, Giovanni Rosti, A. Kramar et al. · Annals of Oncology · 2005 · 285 citations

Oncology, First-line Platinum Chemotherapy, Randomised Trial +8

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

Riccardo Saccardi, Tomáš Kozák, Chiara Bocelli‐Tyndall et al. · Multiple Sclerosis Journal · 2006 · 216 citations

Cell Therapy, Immunology, Immunotherapy +19